A Unique TGFBI Protein in Granular Corneal Dystrophy Types 1 and 2

REFERENCES

• Skonier J, Neubauer M, Madisen L et al. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol 1992;11:511–522.
   PubMed Web of Science ®Google Scholar
• Weiss JS, Møller HU, Lisch W et al. The IC3D classification of the corneal dystrophies. Cornea 2008;27 Suppl 2:S1–83.
   PubMed Web of Science ®Google Scholar
• Garner A. Histochemistry of corneal granular dystrophy. Br J Ophthalmol 1969;53:799–807.
   Google Scholar
• Jones ST, Zimmerman LE. Histopathologic differentiation of granular, macular and lattice dystrophies of the cornea. Am J Ophthalmol 1961;51:394–410.
   Google Scholar
• Eiberg H, Møller HU, Berendt I et al. Assignment of granular corneal dystrophy Groenouw type I (CDGG1) to chromosome 5q. Eur J Hum Genet 1994;2:132–138.
   Google Scholar
• Stone EM, Mathers WD, Rosenwasser GO et al. Three autosomal dominant corneal dystrophies map to chromosome 5q. Nat Genet 1994;6:47–51.
   PubMed Web of Science ®Google Scholar
• Munier FL, Korvatska E, Djemaï A et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997;15:247–251.
   PubMed Web of Science ®Google Scholar
• Klintworth GK, Valnickova Z, Enghild JJ. Accumulation of beta ig-h3 gene product in corneas with granular dystrophy. Am J Pathol 1998;152:743–748.
   Google Scholar
• Runager K, Enghild JJ, Klintworth GK. Focus on molecules: Transforming growth factor beta induced protein (TGFBIp). Exp Eye Res 2008;87:298–299.
   PubMed Web of Science ®Google Scholar
• Korvatska E, Henry H, Mashima Y et al. Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. J Biol Chem 2000;275:11465–11469.
   PubMedGoogle Scholar
• Zerovnik E. Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur J Biochem 2002;269:3362–3371.
   PubMedGoogle Scholar
• Kim JE, Han MS, Bae YC et al. Anterior segment dysgenesis after overexpression of transforming growth factor-beta-induced gene, beta igh3, in the mouse eye. Mol Vis 2007;13:1942–1952.
   PubMed Web of Science ®Google Scholar
• Grothe HL, Little MR, Cho AS et al. Denaturation and solvent effect on the conformation and fibril formation of TGFBIp. Mol Vis 2009;15:2617–2626.
   Google Scholar
• Han YP, Sim AJ, Vora SC et al. Unique TGFBI protein in lattice corneal dystrophy. Invest Ophthalmol Vis Sci 2011;52:8401–8406.
   Google Scholar
• Yuan C, Reuland JM, Lee L et al. Optimized expression and refolding of human keratoepithelin in BL21 (DE3). Protein Expr Purif 2004;35:39–45.
   Google Scholar
• Noble JE, Bailey MJA. “Quantitation of Protein”. Methods Enzymol 2009;463:73–95.
   PubMed Web of Science ®Google Scholar
• Patel DA, Chang SH, Harocopos GJ et al. Granular and lattice deposits in corneal dystrophy caused by R124C mutation of TGFBIp. Cornea 2010;29:1215–1222.
   Google Scholar
• Mashima Y, Nakamura Y, Noda K et al. A novel mutation at codon 124 (R124L) in the BIGH3 gene is associated with a superficial variant of granular corneal dystrophy. Arch Ophthalmol 1999;117:90–93.
   PubMedGoogle Scholar
• Konishi M, Yamada M, Nakamura Y et al. Immunohistology of kerato-epithelin in corneal stromal dystrophies associated with R124 mutations of the BIGH3 gene. Curr Eye Res 2000;21:891–896.
   Web of Science ®Google Scholar
• Gruenauer-Kloevekorn C, Clausen I, Weidle E et al. TGFBI (BIGH3) gene mutations in German families: two novel mutations associated with unique clinical and histopathological findings. Br J Ophthalmol 2009;93:932–937.
   Google Scholar
• Kim JE, Park RW, Choi JY et al. Molecular properties of wild-type and mutant betaIG-H3 proteins. Invest Ophthalmol Vis Sci 2002;43:656–661.
   Google Scholar
• Morand S, Buchillier V, Maurer F et al. Induction of apoptosis in human corneal and HeLa cells by mutated BIGH3. Invest Ophthalmol Vis Sci 2003;44:2973–2979.
   Google Scholar
• Zinn K, McAllister L, Goodman CS. Sequence analysis and neuronal expression of fasciclin I in grasshopper and Drosophila. Cell 1988;53:577–587.
   PubMed Web of Science ®Google Scholar
• Suesskind D, Auw-Haedrich C, Schorderet DF et al. Keratoepithelin in secondary corneal amyloidosis. Graefes Arch Clin Exp Ophthalmol 2006;244:725–731.
   Google Scholar
• Munier FL, Frueh BE, Othenin-Girard P et al. BIGH3 mutation spectrum in corneal dystrophies. Invest Ophthalmol Vis Sci 2002;43:949–954.
   PubMed Web of Science ®Google Scholar
• Korvatska E, Munier FL, Chaubert P et al. On the role of kerato-epithelin in the pathogenesis of 5q31-linked corneal dystrophies. Invest Ophthalmol Vis Sci 1999;40:2213–2219.
   Google Scholar
• Chakravarthi SV, Kannabiran C, Sridhar MS et al. TGFBI gene mutations causing lattice and granular corneal dystrophies in Indian patients. Invest Ophthalmol Vis Sci 2005;46:121–125.
   PubMedGoogle Scholar
• Mashima Y, Yamamoto S, Inoue Y et al. Association of autosomal dominantly inherited corneal dystrophies with BIGH3 gene mutations in Japan. Am J Ophthalmol 2000;130:516–517.
   Google Scholar
• Kim SW, Hong S, Kim T et al. Characteristic features of granular deposit formation in granular corneal dystrophy type 2. Cornea 2011;30:848–854.
   Google Scholar
• Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci 1999;24:329–332.
   PubMed Web of Science ®Google Scholar
• Fändrich M, Fletcher MA, Dobson CM. Amyloid fibrils from muscle myoglobin. Nature 2001;410:165–166.
   PubMed Web of Science ®Google Scholar
• Munishkina LA, Fink AL, Uversky VN. Conformational prerequisites for formation of amyloid fibrils from histones. J Mol Biol 2004;342:1305–1324.
   PubMedGoogle Scholar
• Schmitt-Bernard CF, Chavanieu A, Herrada G et al. BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro. Eur J Biochem 2002;269:5149–5156.
   PubMedGoogle Scholar
• Choi SI, Kim BY, Dadakhujaev S et al. Inhibition of TGFBIp expression by lithium: implications for TGFBI-linked corneal dystrophy therapy. Invest Ophthalmol Vis Sci 2011;52:3293–3300.
   PubMed Web of Science ®Google Scholar